BOUNDLESS BIO, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.015 USD | -1.90% |
|
+3.27% | 0.00% |
| Apr. 22 | Guggenheim Starts Coverage on Boundless Bio With Buy Rating, $24 Price Target | MT |
| Apr. 22 | Piper Sandler Starts Audentes Therapeutics With Overweight Rating, $20 Price Target | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 10.00 | 13.62 | 11.64 |
| Spread/Res. | -9.95% | -33.88% | -22.64% |
| Spread/Supp. | +5.32% | +5.32% | +4.83% |
| Support | 8.550 | 8.550 | 8.590 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- BOLD Stock
- Charts Boundless Bio, Inc.
